Drug industry

Drug industry

Achieving health for all: the epp report

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Media Type: 
Paper
Author: 
DArcy McKillop Farlow
Edition: 
Vol 8, No.3
Publisher: 
Women Healthsharing
Publication Date: 
1987
Publication Place: 
Toronto, ON

This article examines The Epp Report. Discuses the proposed movement from the individual model. Illustrates the value of the report in terms of health promotion and health strategies.

Unsafe by any name

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Media Type: 
Paper
Author: 
Carla Marcelis
Mira Shiva
Edition: 
Vol 7, No.4
Publisher: 
Women Healthsharing
Publication Date: 
1986
Publication Place: 
Toronto, ON

This article discusses how the marketing of controversial drugs in developing countries demonstrates the power and priorities of the pharmaceutical industry. Example highlighted: Estrogen-Progesterone combination drugs. 

Ask your mother

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Media Type: 
Paper
Author: 
Maureen McEvoy
Edition: 
vol 4, No.3
Publisher: 
Women Healthsharing
Publication Date: 
1983
Publication Place: 
Toronto, ON

This article shares the story of Diethylstilbestrol, commonly known as DES, a drug introduced in the forties to prevent miscarriage. Identifies harmful effects on daughters and sons of women who took this drug.

Losing control: the story of hospital work

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Media Type: 
Paper
Author: 
Joan Newman Kuyek
Edition: 
vol 3, No.4
Publisher: 
Women Healthsharing
Publication Date: 
1982
Publication Place: 
Toronto, ON

This article illustrates, through a historical overview, how our concerns as patients are inseparably linked with the structure of hospital work and the well being of workers. Proposes a united and creative front in the battle to end the dehumanization of patients and workers. 

The case against depo provera

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Media Type: 
Paper
Author: 
Janis Sarra
Edition: 
vol 3, No. 1
Publisher: 
Women Healthsharing
Publication Date: 
1982
Publication Place: 
Toronto, ON

This article discusses depo provera. Highlights the controversy of discriminatory and unsafe research methods, discusses the drug industry, potential health effects on women, racist practices. 

The perils pain killers

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Media Type: 
Paper
Author: 
Leslie Storozuk
Edition: 
Vol 1, No. 3
Publisher: 
Women Healsharing
Publication Date: 
1980
Publication Place: 
Toronto, ON

This article discusses the serious problem of over-the-counter (OTC) analgesic abuse; questions why this is predominantly a women’s problem, causes kidney damage, critically explores the role of advertising and big business in women’s increased consumption of OTC’s.


 

 

Sex, lies & pharmaceuticals: how drug companies plan to profit from “female sexual dysfunction” (webinar)

Text Size: Normal / Medium / Large
Resource Language: 
English
Owning Org: 
Canadian Women's Health Network (CWHN)
Media Type: 
Online
Publisher: 
Canadian Women’s Health Network, 2010
Publication Date: 
2010
Publication Place: 
Winnipeg, MB

Drug assessment specialist Dr. Barbara Mintzes looks at the ways women’s sexual difficulties are being repackaged as symptoms of a disorder called “female sexual dysfunction” in order to feed a marketing machine that promises to “cure” it. Dr. Mintzes and Ray Moynihan co-authored the book, Sex, Lies, and Pharmaceuticals.

Order Information: 
Listen to webinar online.

‘Get with the Program!’: pharmaceutical marketing, symptom checklists and self-diagnosis

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Author: 
Mary Ebeling
Edition: 
73(6):825-32
Publisher: 
Social Science and Medicine
Publication Date: 
July 26, 2011

Reviews and analyzes disease awareness campaigns sponsored by pharmaceutical companies that use self-diagnostic tools. Uses the example of premenstrual dysphoric disorder (PMDD) to discuss how the marketing of self-diagnosis can change the patient into a consumer to achieve the aims of drug companies. (Abstract only)

Notes: 
Abstract only is available without subscription. doi: 10.1016/j.socscimed.2011.05.054.

Legal drug-pushing: how disease mongers keep us all doped up

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Author: 
John-Manuel Andriote
Publisher: 
The Atlantic
Publication Date: 
April 2, 2012

Argues that pharmaceutical companies increase consumer demand for more screening and medications by manipulating our fear of suffering and death. 

Order Information: 
Available online.

Working for consumer rights, safe medicines and products

Text Size: Normal / Medium / Large
Resource Language: 
English
Media Type: 
Online
Publisher: 
Pharmawatch Canada

PharmaWatch’s blog seeks to shed light on some of the most significant policy, research, legislative and program issues related to the safety and efficacy of prescription drugs, vaccines and medical devices in Canada. They believe that the Canadian public, patients, physicians, policy analysts, researchers, academics, authors, politicians and the media have a right to know how our drug approval and monitoring system works, how it compares to other international jurisdictions, the factors influencing decision making and whether Health Canada is protecting our health and safety.

Available From: 
Order Information: 
Visit their website to read online.
Syndicate content